New drug combo tested for deadly brain cancer
NCT ID NCT04216329
Summary
This early-stage trial is testing whether adding an experimental drug called selinexor to standard radiation and chemotherapy is safe for people with newly diagnosed glioblastoma, an aggressive brain cancer. Researchers want to find the highest dose of selinexor that patients can tolerate without severe side effects when combined with the usual treatments. The study involves a small group of adults who have not yet received chemotherapy or radiation for their cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.